Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000254942 | SCV000322704 | likely pathogenic | not provided | 2016-09-07 | criteria provided, single submitter | clinical testing | A novel H269R variant that is likely pathogenic was identified in the PCCA gene. It has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The H269R variant was not observed in approximately 6,400 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The H269R variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, this variant is likely pathogenic; however, the possibility that it is benign cannot be excluded. |